Exosomal Contents Guided Amino Acids Treatment for Pancreatic Cancer
外泌体内容物引导氨基酸治疗胰腺癌
基本信息
- 批准号:10434501
- 负责人:
- 金额:$ 16.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-02 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAmino AcidsBreathingCell DeathCell SurvivalCell secretionCellsCellular AssayClinical TrialsDiseaseDisease ProgressionDistantDistant MetastasisEndocytosisEpithelialExcisionExocytosisHumanImpairmentIn VitroIncidenceInvestigationLeadLengthMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMonitorNeoplasm MetastasisNon-MalignantNormal tissue morphologyOperative Surgical ProceduresOutcomePancreasPancreatic AdenocarcinomaPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacologyProteinsProteomeProteomicsQuality of lifeSchemeSideSolidSurvival RateTherapeuticTherapeutic EffectTreatment CostWorkadvanced diseasecell typechemoradiationchemotherapycomparativedietary supplementseffective therapyefficacy studyexosomeimprovedin vivoneoplastic cellnovelnovel therapeutic interventionnovel therapeuticspre-clinicalpreclinical studyside effectstressortumortumor progressiontumor xenograft
项目摘要
PROJECT SUMMARY/ABSTRACT
With a 5-year survival rate of less than 5%, Pancreatic adenocarcinoma (PDAC) is a lethal condition with poor
outcomes and an increasing incidence. Surgical resection is the only treatment that offers a potential cure, but
was limited to the early stage cases without distant metastasis. Currently, there are scarce effective treatments
for advanced disease. Chemoradiation and systemic chemotherapy are the mainstay of treatment to slow
disease progression at advanced stages. But these therapies cause various side effects, which is one major
barrier to the efficacy of anti-tumor therapeutics. There are no known medications that can selectively protect
normal tissues from these side effects, and thus an urgent need for novel treatment selectively targeting only
tumor cells to improve patient outcomes.
Exosomes secreted by tumor cells actively participate in tumor progression and metastasis and contain multiple
biomolecules reflecting the status of their parental tumor cells. Investigation of the exosomal contents may lead
to a therapeutic inspiration for cancer. We conducted comparative proteomics studies over the malignant and
nonmalignant cells at both the cellular and exosomal level. Significant different proteome sets have been
identified between the malignant and nonmalignant cells at all levels. Since amino acids are the formation unit
of the protein primary sequence, we furthered the proteomics results by studying the distribution of the amino
acids statistically between the malignant and nonmalignant cells at both cellular and exosomal level. We found
a significant imbalanced amino acid distribution between the tumor cells and exosomes, which is not found
between nonmalignant cells and exosomes. This indicates that tumor cells selectively flux certain amino acids
out of cells through exosomes, which inspired us to use these amino acids as stressors to tumor cells. The cell
viability of the tumor cells treated by these amino acids was significantly decreased, but not that of nonmalignant
cells. This exosome-guided observation potentiates a new therapeutic intervention selectively targeting tumor
cells. In order to develop the finding into a therapeutic choice for pancreatic cancer, we propose to preclinically
validate the treatment in vivo and study the mechanism in vitro.
项目总结/摘要
胰腺癌(PDAC)的5年生存率低于5%,是一种致命疾病,生存率低。
结果和增加的发病率。手术切除是唯一可能治愈的治疗方法,但
仅限于无远处转移的早期病例。目前,缺乏有效的治疗方法,
治疗晚期疾病放化疗和全身化疗是治疗的主要手段,
疾病进展到晚期。但这些疗法会引起各种副作用,这是一个主要的
抗肿瘤治疗剂的功效的障碍。没有已知的药物可以选择性地保护
正常组织免受这些副作用的影响,因此迫切需要选择性靶向仅
肿瘤细胞,以改善患者的预后。
由肿瘤细胞分泌的外泌体积极参与肿瘤进展和转移,并含有多种
反映其亲本肿瘤细胞状态的生物分子。外泌体内容物的研究可能导致
癌症治疗的灵感。我们对恶性和恶性肿瘤进行了比较蛋白质组学研究,
非恶性细胞在细胞和外泌体水平。显著不同的蛋白质组集已经被
恶性和非恶性细胞之间的所有水平。由于氨基酸是形成单位
蛋白质一级序列的氨基酸分布,进一步研究了蛋白质组学结果,
在细胞水平和外泌体水平上,恶性和非恶性细胞之间的酸统计学差异。我们发现
肿瘤细胞和外泌体之间的氨基酸分布显著不平衡,未发现
非恶性细胞和外来体之间的联系这表明肿瘤细胞选择性地将某些氨基酸
这启发了我们使用这些氨基酸作为肿瘤细胞的应激源。细胞
用这些氨基酸处理的肿瘤细胞的存活率显著降低,但非恶性肿瘤细胞的存活率没有降低。
细胞这种外泌体引导的观察增强了选择性靶向肿瘤的新治疗干预
细胞为了将这一发现发展为胰腺癌的治疗选择,我们建议在临床前
在体内验证治疗效果,并在体外研究其作用机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dali Sun其他文献
Dali Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dali Sun', 18)}}的其他基金
Exosomal Contents Guided Amino Acids Treatment for Pancreatic Cancer
外泌体内容物引导氨基酸治疗胰腺癌
- 批准号:
10984608 - 财政年份:2022
- 资助金额:
$ 16.95万 - 项目类别:
Exosomal Contents Guided Amino Acids Treatment for Pancreatic Cancer
外泌体内容物引导氨基酸治疗胰腺癌
- 批准号:
10560594 - 财政年份:2022
- 资助金额:
$ 16.95万 - 项目类别:
Using the secondary structure (beta-sheet) of exosomal proteins for noninvasive pancreatic cancer detection
利用外泌体蛋白的二级结构(β-折叠)进行非侵入性胰腺癌检测
- 批准号:
10046870 - 财政年份:2020
- 资助金额:
$ 16.95万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 16.95万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 16.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 16.95万 - 项目类别: